Angiochem to Present at EANO 2016 Meeting
MONTREAL, QC--(Marketwired - October 11, 2016) - Angiochem, a biotechnology company developing peptide drug conjugates uniquely capable of crossing the blood-brain barrier, announced it will make an oral presentation during the Non Glioma session at the …